Here we took advantage of a mouse pancreatic cancer model containing a unique reporter system to trace genome evolution after sporadic p53 inactivation during a previously inaccessible phase of cancer evolution initiated by p53 loss of function—at the benign-to-malignant transition. This evidence concerns the gene TP53 and familial pancreatic carcinoma.